Literature DB >> 3907947

Bronchoalveolar lavage in patients with the adult respiratory distress syndrome.

S Idell, A B Cohen.   

Abstract

BAL in patients with ARDS provides material containing the soluble and cellular constituents of the alveolar compartment, and hence is a useful tool for the study of the pathogenesis of ARDS. The technique is imperfect as it is prone to problems of data acquisition and interpretation. However, it is lung-specific and may be used in serial studies of patients over the course of their disease. A large amount of evidence is rapidly being accumulated which documents the presence of effectors of inflammation in the BAL fluids of patients with ARDS. Confirmation of the importance of such mediators, pathways, or cellular constituents of BAL fluid in establishing the pathogenesis of ARDS ultimately depends upon proof of the efficacy of specific clinical interventions which both arrest the activity of the effector and predictably alter the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907947

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  Acute respiratory distress syndrome mimickers lacking common risk factors of the Berlin definition.

Authors:  Aude Gibelin; Antoine Parrot; Bernard Maitre; Christian Brun-Buisson; Armand Mekontso Dessap; Muriel Fartoukh; Nicolas de Prost
Journal:  Intensive Care Med       Date:  2015-09-25       Impact factor: 17.440

2.  Adrenomedullin suppresses fMLP-induced upregulation of CD11b of human neutrophils.

Authors:  Y Saito; C Nakagawa; H Uchida; F Sasaki; H Sakakibara
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

3.  Kinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury.

Authors:  Li Ma; Ciara M Shaver; Brandon S Grove; Daphne B Mitchell; Nancy E Wickersham; Robert H Carnahan; Tracy L Cooper; Brittany E Brake; Lorraine B Ware; Julie A Bastarache
Journal:  Clin Transl Med       Date:  2015-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.